In Q1 2023, Russian manufactures produced 167.6 billion rubles’ worth of ready-made pharmaceutical drugs (manufacturer’s prices, VAT included), down 9.8% from Q1 2022. In physical terms, the production was 0.98 billion packages, down 10.3% from Q1 2022. If calculated in minimum dosage units (MDU), the production went down 3.9%, with 19.1 billion MDUs.
4/13/2023 Study by RNC Pharma and Medvestnik: 70% of Russian Doctors Want to Leave Public Healthcare Due to Low Salaries and Overwork, 30% Would Leave if Offered Decent Alternatives
39.6% of physicians think they could leave public healthcare in favor of a private medical institution due to “unjustifiably low salaries”, according to a survey conducted by the RNC Pharma analyst company and the Medvestnik platform for doctors. Another popular reason is “excessive workload and constant overwork”, voted by 31.3% of the respondents.
4/10/2023 Study by RNC Pharma and Medvestnik: 72% of Russian Doctors Want to Retrain, 21% Actually Plan to
While most Russian physicians would like to be able to have additional training in a narrower specialty, the options offered by the Ministry of Health are not suitable for 28.9%, according to a survey conducted by the RNC Pharma analyst company and the Medvestnik platform for doctors.
In February 2023, Russian manufacturers produced 100.1 billion rubles’ worth of ready-made pharmaceutical drugs (manufacturer’s prices, VAT included), down 12.6% from February 2022.
In 2022, the online sales or reservations of pharmaceutical products (pharmaceutical drugs and parapharmaceuticals) in Russia were 294.6 billion rubles (end-user prices, VAT included), 40.3% up from 2021, when the growth rate was 53%.
3/2/2023 RNC Pharma: Product Range and Promotion Changes in Store for Pharmaceutical Retail in First Half of 2023
2022 Ranking of Russian Pharmacy Chains.
2022 Ranking of Russian Pharmaceutical Distributors.
2/27/2023 Study by RNC Pharma and Medvestnik: More Than 55% of Russian Physicians Are Not Sure How New Compensations Work
In early February, branches of the Social Fund of the Russian Federation began distributing special payments to doctors as part of a government program to support healthcare workers.
In 2022, Russia imported 15.9 billion rubles’ worth of veterinary vaccines (EEU imports excluded; customs clearance and VAT included), up 3.4% from 2021)—practically the same as in the past three years. In physical terms, 7 million packages were imported, up 14.9% from 2021. If calculated in doses, the import was 21.7 billion, up 19.8% from 2021.
In 2022, Russia imported 38.2 billion rubles’ worth of veterinary drugs (customs clearance and VAT included; imports from EEU countries excluded), up only 2.8% from 2021, although the import volume was record-worthy. In physical terms, Russia imported around 34.1 million packages, up 7.1% from 2021. As for feed supplements, imports went down 5.2%, with 41 billion rubles’ worth of products. In physical terms, Russia imported 149,700 tons, down 7.7% from 2021.